AI주식인사이트AI Stock Insight
C

케어젠

214370KOSDAQ기초 의약물질 제조업

45.2 / 100

Reference Date: 2026-04-13

Financial Score15.0 / 40
News Sentiment10.2 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 28.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Caregen develops and sells pharmaceuticals, health supplements, medical devices, and cosmetics based on biomimetic peptides and growth factor proteins, leveraging a large peptide library with over 860 patents. The company offers key products such as blood sugar regulators, muscle health supplements, and weight management solutions, and is expanding into new drug pipelines for conditions like macular degeneration, diabetes, and hair loss through global sales in 130 countries.

Number of Employees

201people

Average Salary

50.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
208.27Industry Average 33.450.0Point

6.2x industry avg (risky)

PBR
—Industry Average 2.033.5Point
ROE
9.23Industry Average -4.293.5Point

Well below industry avg

Debt Ratio
4.90Industry Average 6.615.0Point

Lower than industry avg (good)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼3.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼27.8% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 13.9% (declining, 3yr)

Detailed News Sentiment

11 totalPositive 0Neutral 5Negative 1Average Sentiment Score 33.3

Detailed Momentum

52-week position5.0Point

52w mid range (49%)

Current 85,600Won52-week high 150,10052-week low 23,400
1-month return0.0Point

1m -28.07% (strong drop)

Volume trend5.0Point

Volume flat

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-10
  • Neutral주식등의대량보유상황보고서(일반)2026-04-10
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-31
  • Neutral주식등의대량보유상황보고서(일반)2026-03-31
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-25